specialti pharmaceut compani
oper two busi segment
acut segment revenue-gener
contract develop manufactur
oper contract
manufactur busi gainesvil georgia
reason report
addit spin thought rais pt
review spin-out baudax file ad
addit takeaway notabl compani
separ manag team current manag
team lead therapeut spin-out baudax beg question
lead go forward regardless
file clariti around potenti separ
two busi ultim highlight profit
cash flow stand-alone result rais pt
pf ebitda
ascrib valu therapeut arm bull case scenario
multipl get stock
thought file
pay baudax million cash estim
baudax cash need month follow spin
current manag team ceo gerri henwood cfo
ryan lake expect lead baudax compani note
part strategi behind separ two compani
two separ distinct manag team
appear retain consolid compani debt
unclear us happen nol
baudax determin good good faith alloc tax
provid servic baudax month post spin
distribut ratio spin yet determin
baudax list ticker
strategi behind separ compani includ
give compani opportun flexibl pursu
invest capit alloc growth strategi
creat two separ distinct manag team
better align corpor perform goal specif
vision strategi object busi
allow investor separ valu busi
thought valuat launch univers
feedback receiv holder multipl
assign low updat valuat
analysi exact cash distribut baudax along
cash exercis option also assum
multipl line trade
increas biolog exposur get us pt
receiv question around privat equiti interest
asset insight howev find interest
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
current manag team lead baudax go forward outlin recent transact
compar would permira fund bid cambrex cbm valu cbm ntm ebitda assum
compar multipl would yield stock view blue sky scenario share
current public
paragon bioservic inc acquir
brammer acquir
avista pharma solut acquir cbm
pharma acquir cbm
acquir
cook pharmaica acquir
patheon acquir
capsugel acquir lonza
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
